Surviving Mesothelioma Reports on Mesothelioma Immunotherapy Trial Planned at Baylor

Share Article

The newly-announced first-in-human clinical trial will combine immunotherapy and surgery for the treatment of malignant pleural mesothelioma.

New Trial Combines Immunotherapy and Surgery

New Immunotherapy Trial for Mesothelioma

I predict that immunotherapy will rise to become a critical component of multimodality therapy for mesothelioma patients.

A new study combining immunotherapy drugs and mesothelioma surgery could mark the future for mesothelioma therapy. Surviving Mesothelioma has just posted an article on the clinical trial being run by the Baylor College of Medicine. Click here to read it now.

Baylor announced earlier this week that it is recruiting pleural mesothelioma patients to receive either one or two immunotherapy drugs followed by cytoreductive surgery to remove the visible mesothelioma tumors.

“I predict that immunotherapy will rise to become a critical component of multimodality therapy for mesothelioma patients,” says Dr. Bryan Burt, assistant professor of surgery at Baylor and principal investigator on the trial.

The study, announced this week on the Baylor website, is the first to involve administration of immunotherapy drugs prior to, rather than following, mesothelioma surgery.

“By reactivating the immune system to help fight mesothelioma, it is hoped that these immunotherapy drugs will increase the odds of surviving this hard-to-treat cancer,” says Alex Strauss, Managing Editor of Surviving Mesothelioma.

You can read more about the Baylor study and about immunotherapy for pleural mesothelioma treatment in Baylor to Test New Combination Therapy for Mesothelioma, now available on the Surviving Mesothelioma website.

Benson, Dana, “Mesothelioma Treatment Center at Baylor St. Luke’s launches Clinical Trial for cancer patients”, September 6, 2016, News Release, Baylor College of Medicine website, https://www.bcm.edu/news/lung/mesothelioma-treatment-center-clinical-trial

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website